Sensorial Evaluation of Eslicarbazepine Acetate Oral Suspension
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-002-Tuesday
- By: ALMEIDA, Hugo (Bial - Portela & Cª, S.A., R&D Department - Pharmaceutical Development, Coronado (S. Romão e S. Mamede), Portugal)
- Co-author(s): Hugo Miguel Almeida: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
Teofilo Vasconcelos: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
Ricardo Lima: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
Patrício Soares-da-Silva: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal - Abstract:
Backgrounds
Sensorial evaluation of an oral suspension is a critical parameter in the development of this oral dosage form.Aims
To describe the study conducted to assess palatability and acceptability by adult humans of eslicarbazepine acetate oral suspension.
Methods
Two adult panels were submitted to the study: one in Europe (7 males + 7 females)
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023